T-knife GmbH
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Other Names/Subsidiaries
- T-knife Therapeutics, Inc.
See more in Biomedtracker
Latest on T-knife GmbH
Scrip
• By Eleanor Malone
“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office
Scrip
• By Mandy Jackson
Venture capital mega-rounds of $100m or more are driving record levels of VC investment in biopharmaceutical companies, and these big financings have not taken a summer break. [Sidebar#SC144714] The l
Scrip
• By Kevin Grogan
Just 12 months after closing a $78.2m series A round, German biotech T-knife GmbH has raised another $110m in a series B financing round to help drive its pipeline of next-generation T-cell receptor